Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Full Paper
  • Published:

A weak association of HLA-B*2702 with Behçet’s disease

Abstract

This study aimed to analyse the association of HLA-B alleles other than -B51 with Behçet’s disease (BD). We also investigated the frequency of HLA-B alleles sharing the same natural killer cell immunoglobulin-like receptor (KIR) binding sequence with HLA-B51. Broad-genotyping of HLA-B locus by PCR-SSOP in 174 Turkish BD patients and 191 healthy controls confirmed the strong association of B*51 with BD (60.9% in BD patients, 24.6% in healthy controls, OR = 4.78). No other HLA-B allele was identified showing an association with BD after adjusting for multiple testing or by using relative predispositional effects (RPE) analysis after the deletion of B*51. HLA-B alleles reacting with the sequence specific oligonucleotide probe 23, which corresponds to the KIR binding site of B*51, were found to be positive in 127 BD patients (73%) and 90 controls (47%) (OR = 3.03, 95% CI 2–4.7). The repeated RPE analysis after separating HLA-B alleles carrying B51-KIR binding sequence as distinct alleles within a broad-type allele group revealed B*2702 allele as the only allele showing an association with BD after the deletion of B*51. Selective increase of B*2702, the only B*27 allele carrying the same KIR binding sequence with B*51, warrants investigation of the possibility of interaction of HLA molecules with KIRs on NK or other T cells in the pathogenesis of BD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G . Behçet’s disease N Engl J Med 1999 341: 1284–1291

    Article  CAS  PubMed  Google Scholar 

  2. Gül A . Behçet’s disease: an update on the pathogenesis Clin Exp Rheum 2001 19(Suppl 24): S6–S12

    Google Scholar 

  3. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M . Close association of HLA-Bw51 with Behçet’s disease Arch Ophthalmol 1982 100: 1445–1458

    Article  Google Scholar 

  4. Mizuki N, Ohno S, Tanaka H et al. Association of HLA-B51 and lack of association of class II alleles with Behçet’s disease Tissue Antigens 1992 40: 22–30

    Article  CAS  PubMed  Google Scholar 

  5. Müftüoglu AU, Yazici H, Yurdakul S et al. Behçet’s disease: lack of correlation of clinical manifestations with HLA antigens Tissue Antigens 1981 17: 226–230

    Article  PubMed  Google Scholar 

  6. Chajek-Shaul T, Pisanty S, Knobler H et al. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet’s syndrome Am J Med 1987 83: 666–672

    Article  CAS  PubMed  Google Scholar 

  7. Balboni A, Pivetti-Pezzi P, Orlando P et al. Serological and molecular HLA typing in Italian Behçet’s patients: significant association to B51-DR5-DQw3 haplotype Tissue Antigens 1992 39: 141–143

    Article  CAS  PubMed  Google Scholar 

  8. Lehner T, Batchelor JR, Challacombe SJ, Kennedy L . An immunogenetic basis for the tissue involvement in Behçet’s syndrome Immunology 1979 37: 895–900

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Kilmartin DJ, Finch A, Acheson RW . Primary association of HLA-B51 with Behcet’s disease in Ireland Br J Ophthalmol 1997 81: 649–653

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mizuki N, Ohno S, Sato T et al. Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet’s disease Hum Immunol 1995 43: 129–135

    Article  CAS  PubMed  Google Scholar 

  11. Mizuki N, Ota M, Kimura M et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease Proc Natl Acad Sci USA 1997 94: 1298–1303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Mizuki N, Inoko H, Ohno S . Pathogenic gene responsible for the predisposition to Behçet’s disease Intern Rev Immunol 1997 14: 33–48

    Article  CAS  Google Scholar 

  13. Ota M, Mizuki N, Katsuyama Y et al. The critical region for Behçet’s disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping Am J Hum Genet 1999 64: 1406–1410

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mizuki N, Ota M, Yabuki K et al. Localization of the pathogenic gene of Behcet’s disease by microsatellite analysis of three different populations Invest Ophthalmol Vis Sci 2000 41: 3702–3708

    CAS  PubMed  Google Scholar 

  15. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL . NKB1: A natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules J Exp Med 1994 180: 537–543

    Article  CAS  PubMed  Google Scholar 

  16. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M . NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80 J Exp Med 1994 180: 1235–1242

    Article  CAS  PubMed  Google Scholar 

  17. Lanier LL . NK cell receptors Annu Rev Immunol 1998 16: 359–393

    Article  CAS  PubMed  Google Scholar 

  18. Mingari MC, Moretta A, Moretta L . Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T cell responses Immunol Today 1998 19: 153–157

    Article  CAS  PubMed  Google Scholar 

  19. Payami H, Joe S, Farid NR et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease Am J Hum Genet 1989 45: 541–546

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Thomson G, Robinson WP, Kuhner MK, Joe S, Klitz W . HLA and insulin gene associations with IDDM Genet Epidemiol 1989 6: 155–160

    Article  CAS  PubMed  Google Scholar 

  21. Thomson G . HLA disease associations: models for the study of complex human genetic disorders Crit Rev Clin Lab Sci 1995 32: 183–219

    Article  CAS  PubMed  Google Scholar 

  22. Mu H, King MC, Criswell LA . Relative predispositional effects and mode of inheritance of HLA-DRB1 alleles among community-based Caucasian females with rheumatoid arthritis Genet Epidemiol 1998 15: 123–134

    Article  CAS  PubMed  Google Scholar 

  23. Lin L, Tokunaga K, Tanaka H et al. Further molecular diversity in the HLA-B15 group Tissue Antigens 1996 47: 265–274

    Article  CAS  PubMed  Google Scholar 

  24. Kurhan-Yavuz S, Direskeneli H, Bozkurt N et al. Anti-MHC autoimmunity in Behçet’s disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis Clin Exp Immunol 2000 120: 162–166

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Takeno M, Kariyone A, Yamashita N et al. Excessive function of peripheral blood neutrophils from patients with Behçet’s disease and from HLA-B51 transgenic mice Arthritis Rheum 1995 38: 426–433

    Article  CAS  PubMed  Google Scholar 

  26. Gumperz JE, Barber LD, Valiante NM et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor J Immunol 1997 158: 5237–5241

    CAS  PubMed  Google Scholar 

  27. Kahan A, Hamzaoui K, Ayed K . Abnormalities of T lymphocyte subsets in Behçet’s disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies J Rheumatol 1992 19: 742–746

    CAS  PubMed  Google Scholar 

  28. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y . Increased peripheral blood γδ+ T cells and natural killer cells in Behçet’s disease J Rheumatol 1992 19: 588–592

    CAS  PubMed  Google Scholar 

  29. Hasan A, Fortune F, Wilson A et al. Role of γδ T cells in the pathogenesis and diagnosis of Behçet’s disease Lancet 1996 347: 789–794

    Article  CAS  PubMed  Google Scholar 

  30. Young C, Lehner T, Barnes CG . CD4 and CD8 cell responses to herpes simplex virus in Behcet’s disease Clin Exp Immunol 1988 73: 6–10

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Hamzaoui K, Ayed Kh, Slim A, Hamza M, Touraine JL . Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet’s disease Clin Exp Immunol 1990 79: 28–34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Buelow R, Veyron P, Clayberger C, Pouletty P, Touraine J-L . Prolongation of skin allograft in mice following administration of allotrap Transplantation 1995 59: 455–460

    Article  CAS  PubMed  Google Scholar 

  33. Giral M, Cuturi M-C, Nguyen J-M et al. Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide Transplantation 1997 63: 1004–1011

    Article  CAS  PubMed  Google Scholar 

  34. Peruzzi M, Wagtmann N, Long EO . A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705 J Exp Med 1996 184: 1585–1590

    Article  CAS  PubMed  Google Scholar 

  35. Smith KD, Kurago ZB, Lutz CT . Corformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system Immunol Res 1997 16: 243–259

    Article  CAS  PubMed  Google Scholar 

  36. Gonzalez-Roces S, Alvarez MV, Gonzalez S et al. HLA-B27 polymorphism and worldwide susceptiblity to ankylosing spondylitis Tissue Antigens 1997 49: 116–123

    Article  CAS  PubMed  Google Scholar 

  37. International Study Group for Behcet’s Disease. Criteria for diagnosis of Behçet’s disease Lancet 1990 335: 1078–1080

  38. Kennedy LJ, Poulton KV, Thomson W et al. HLA class I DNA typing using sequence specific oligonucleotide probes (SSOP) In: Charron D (ed) Genetic Diversity of HLA. Functional and Medical Implication EDK: Paris 1997 pp 216–225

    Google Scholar 

  39. Cereb N, Maye P, Lee S, Kong Y, Yang SY . Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B and -C alleles Tissue Antigens 1995 45: 1–11

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Professor Alan J Silman for his critical reading and suggestions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Gül.

Additional information

This study was supported by University of Istanbul Research Funds, Project No. 1076/031297.

Appendix

Appendix

HLA-B alleles sharing aminoacid sequence of the B*51 between positions 77–82 of the α1-helix: B*0803, B*1513, B*1516, B*1517, B*1523, B*1524, B*1567, B*2702, B*3801, B*3805-B*3807, B*4013, B*4019, B*4406, B*4418, B*4425, B*4901-B*4903, B*5101-B*5127, B*5201-B*5203, B*5301, B*5302, B*5304, B*5306-B*5308, B*5701-B*5709, B*5801, B*5802, B*5804-B*5806, B*5901.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gül, A., Uyar, F., Inanç, M. et al. A weak association of HLA-B*2702 with Behçet’s disease. Genes Immun 3, 368–372 (2002). https://doi.org/10.1038/sj.gene.6363863

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6363863

Keywords

This article is cited by

Search

Quick links